The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Implications of a prognostic 40-gene expression profile (40-GEP) test for high-risk cutaneous squamous cell carcinoma (cSCC) on staging-based risk assessment and adjuvant therapy trial design.
 
Chrysalyne Schmults
Honoraria - Regeneron
Consulting or Advisory Role - Castle Biosciences; Regeneron
Research Funding - Castle Biosciences; Genentech; Novartis; Regeneron
Other Relationship - National Comprehensive Cancer Network
 
Kyle R. Covington
Employment - Castle Biosciences
Stock and Other Ownership Interests - Castle Biosciences
Patents, Royalties, Other Intellectual Property - Castle Biosciences
Travel, Accommodations, Expenses - Castle Biosciences
 
Sarah J. Kurley
Employment - Castle Biosciences
Stock and Other Ownership Interests - Castle Biosciences
Patents, Royalties, Other Intellectual Property - Pending patent application with Castle Biosciences, Inc.
Travel, Accommodations, Expenses - Castle Biosciences
 
Robert W. Cook
Employment - Castle Biosciences
Stock and Other Ownership Interests - Castle Biosciences
Patents, Royalties, Other Intellectual Property - Castle Biosciences
Travel, Accommodations, Expenses - Castle Biosciences